NUSHU Shoe for Gait Analysis in Parkinson's Disease

This study is testing a new shoe device called NUSHU, made by Magnes AG, for people with Parkinson's disease. The NUSHU shoe has sensors that measure how you walk (gait analysis) in real-time. It also provides gentle vibrations (vibrotactile stimulus) that might help with walking difficulties. Researchers want to see how comfortable and easy to use the NUSHU shoe is, and how many people complete the study. You may be able to join if you are at least 18 years old, have Parkinson's disease, can speak English, and are willing to follow study instructions. This study is currently unclear on its recruitment status and aims to enroll 40 participants.

Study design
This interventional study plans to enroll 40 participants with Parkinson's disease. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 18 weeks, with comfort and ease of use measured at the end of this period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06975059

Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients

Suspended
NAAges 18+InterventionalTreatment
Weill Medical College of Cornell University
~40 participants
Updated 2026-08-28 on ClinicalTrials.gov
What's tested:NUSHU shoe

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean Score of Comfort Level of Device in Satisfaction Survey
Measured over At Safety Follow Up (Week 18)
+2 more outcomes measured
Parkinson's Disease (PD)

NCT06975059

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Weill Cornell

    New York, New Yorkno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Harini Sarva, MD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Mean Score of Comfort Level of Device in Satisfaction SurveyAt Safety Follow Up (Week 18)

    The satisfaction survey contains 2 demographic questions and 5 questions about participant satisfaction completed at end of study participation. The comfort level of the device question is the following: How would you rate the comfort level of the device? The scale is 0, 1, 2, 3, 4, 5, with 0 meaning most uncomfortable and 5 meaning most comfortable. Mean score for each individual question will be provided.

  • Mean Score of Ease of Using Device in Satisfaction SurveyAt Safety Follow Up (Week 18)

    The satisfaction survey contains 2 demographic questions and 5 questions about participant satisfaction completed at end of study participation. The comfort level of the device question is the following: How easy was it to use the device? The scale is 0, 1, 2, 3, 4, 5, with 0 meaning very easy and 5 meaning very difficult. Mean score for each individual question will be provided.

  • Ratio of Participants Who Completed Study to Total Number of Participants EnrolledThrough study completion, 18 weeks

    We would like to measure the retention rate to assess feasibility. The lowest ratio would be 0, and the highest ratio would be 1.